Back to today’s briefing

Story perspectives

Breakthrough Peptide Method Targets Key Cancer Protein

3/28/2025

44 7

Summary

Story summary

Researchers at the University of Bath have unveiled a groundbreaking method that harnesses peptides to target cJun, a crucial player in cancer progression. Their innovative Transcription Block Survival (TBS) assay evaluates these peptides, aiming to disable this protein and enhance treatment options for cancer patients by building on earlier discoveries of reversible inhibitors that modify gene expression.

1 of 1

Story summary

Researchers at the University of Bath have unveiled a groundbreaking method that harnesses peptides to target cJun, a crucial player in cancer progression. Their innovative Transcription Block Survival (TBS) assay evaluates these peptides, aiming to disable this protein and enhance treatment options for cancer patients by building on earlier discoveries of reversible inhibitors that modify gene expression.